In the spring of 2002, everything we believed to be true about our water future was upended. A mere 25% of normal runoff cascaded off the slopes of the Rockies and what was to become the most devastating drought in modern times began. In the early years, many desperately wanted to believe this was a temporary phenomenon, but it wasn’t long before their hopes were dashed. A dramatic shift in climate patterns was upon us, and we had to scramble to adapt.

Real estate expert Nicholas Irwin breaks down the latest data and trends around default notices in Las Vegas. Find out what rising notices might mean for the local housing market and homeowners.

Time is running out for lawyers to provide feedback on judges for the Las Vegas Review-Journal’s 2025 Judicial Performance Evaluation. This is the 14th time since 1992 that the news organization has spearheaded the survey, which aims to inform voters and identify the best and worst judges.

Dr. Manoj Sharma, a Professor of Social and Behavioral Health and Internal Medicine, and President of Health for All, Inc., answers queries on breast cancer.

Gov. Joe Lombardo is in the process of authorizing the Nevada National Guard to assist Immigration and Customs Enforcement, his spokesperson confirmed Friday afternoon.

As tourism numbers continue to decline, Las Vegas is strategizing to maintain its status as a top destination.

The United States has issued a travel warning for China due to an outbreak of the chikungunya virus, a mosquito-borne illness. Public health providers in China are currently using sprayers and drones to combat more than 7,000 cases linked to mosquitoes.

After years of booming tourism in Las Vegas, the hot streak looks to be cooling off — and it may be a tell for the broader economy.

Detect Alzheimer's disease early with a groundbreaking blood test that could change the game for millions of people worldwide! This revolutionary diagnostic tool can identify the disease years before symptoms appear, giving patients and their families a head start on treatment and care. The FDA just cleared the first blood test for identifying patients with amyloid pathology associated with Alzheimer’s disease — and part of the research behind its approval was conducted by leading experts at the UNLV Department of Brain Health, with chair and renowned brain health researcher, Jefferson Kinney, PhD, our guest for today’s Show. In this video, we'll dive into the science behind this innovative test, how it works, and what it means for the future of Alzheimer's research and treatment. If you or a loved one is at risk for Alzheimer's, you won't want to miss this!